Bayer Aktiengesellschaft · ISIN: DE000BAY0017 · EQS - adhoc news

Bayer plans to amend its dividend policy to reduce debt

Leverkusen, February 19, 2024 – Bayer AG plans to amend its dividend policy to pay out the legally required minimum for three years. This follows a review of the company’s capital allocation priorities to reduce debt. This change would result in a dividend of 0.11 euros per share for fiscal year 2023. The Board of Management and the Supervisory Board will present this dividend proposal for shareholder vote at the Annual Stockholders’ Meeting on April 26, 2024. This proposal comes as Bayer faces...

XETR:BAYN Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News Bayer Aktiengesellschaft

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (39)
Short Selling (DE) (6)
Short Selling (UK) (0)
19 February 2024 05:23PM
Bayer plans to amend its dividend policy to reduce debt
DE000BAY0017
Leverkusen, February 19, 2024 – Bayer AG plans to amend its dividend policy to pay out the legally required minimum for three years. This follows a review of the company’s capital allocation priorities to reduce debt. This change would result in a dividend of 0.11 euros per share for fiscal year 2023. The Board of Management and the Supervisory Boa...
Bayer Aktiengesellschaft
About the publication
19 November 2023 11:47PM
OCEANIC-AF study stopped early due to lack of efficacy
DE000BAY0017
Leverkusen/Berlin, November 19, 2023 – OCEANIC-AF, a phase III study investigating asundexian compared to apixaban (a direct oral anticoagulant) in patients with atrial fibrillation at risk for stroke is being stopped early. This decision is based on the recommendation of the study’s Independent Data Monitoring Committee (IDMC) as part of ongoing s...
Bayer Aktiengesellschaft
About the publication
24 July 2023 07:32PM
Bayer lowers full-year outlook
DE000BAY0017
Leverkusen, July 24, 2023 – The Bayer Group adjusted its full-year outlook for 2023 downward on Monday, mainly due to a significant further decline in sales of glyphosate-based products. For full-year 2023, Bayer now anticipates sales of between 48.5 billion and 49.5 billion euros on a currency-adjusted basis, i.e. based on the average monthly exch...
Bayer Aktiengesellschaft
About the publication
24 July 2023 07:32PM
Bayer Aktiengesellschaft: Bayer lowers full-year outlook
DE000BAY0017
Leverkusen, July 24, 2023 – The Bayer Group adjusted its full-year outlook for 2023 downward on Monday, mainly due to a significant further decline in sales of glyphosate-based products. For full-year 2023, Bayer now anticipates sales of between 48.5 billion and 49.5 billion euros on a currency-adjusted basis, i.e. based on the average monthly exch...
Bayer Aktiengesellschaft
About the publication
08 February 2023 05:14PM
Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG
DE000BAY0017
Leverkusen, February 8, 2023 Effective June 1, 2023, William N. (Bill) Anderson will become the new Chairman of the Board of Management of Bayer AG. This was decided by the company’s Supervisory Board at its meeting today. Before assuming the position of Chairman of the Board, Bill Anderson will join the Board of Management of Bayer AG on April 1st...
Bayer Aktiengesellschaft
About the publication
08 February 2023 05:14PM
William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG
DE000BAY0017
Leverkusen, February 8, 2023 Effective June 1, 2023, William N. (Bill) Anderson will become the new Chairman of the Board of Management of Bayer AG. This was decided by the company’s Supervisory Board at its meeting today. Before assuming the position of Chairman of the Board, Bill Anderson will join the Board of Management of Bayer AG on April 1st...
Bayer Aktiengesellschaft
About the publication
27 May 2021 01:06AM
Bayer Aktiengesellschaft: Bayer announces five-point plan to effectively address potential future Roundup(TM) claims
DE000BAY0017
Bayer announces five-point plan to effectively address potential future Roundup(TM) claims Leverkusen, May 27, 2021 - Bayer announced today a series of actions it plans to implement following the denial of the motion to preliminarily approve the Roundup(TM) class settlement agreement, designed to address potential future litigation, by Judge Vince...
Bayer Aktiengesellschaft
About the publication
30 September 2020 07:10PM
Bayer Aktiengesellschaft: Bayer to accelerate transformation to address challenging market environment and enable additional growth investments
DE000BAY0017
Leverkusen, September 30, 2020 - Bayer AG announced today that the company confirms its adjusted outlook for 2020 and expects 2021 sales at approximately 2020 levels despite significant headwinds from the COVID-19 pandemic, especially in the agricultural market. Core earnings per share in 2021 are expected to be slightly below 2020 levels at consta...
Bayer Aktiengesellschaft
About the publication
More Bayer Aktiengesellschaft related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 39 19th November 2024 Weisser, Alberto DD
Short Seller (DE) 6 21st November 2024 D. E. Shaw & Co., L.P. SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN